Diminished Benefits of Drug-Eluting Stents versus Bare Metal Stents in Patients with Severe Renal Insufficiency

Publisher： Karger

E-ISSN： 1660-2110|113|3|c198-c202

ISSN： 1660-2110

Source： Nephron Clin Pract, Vol.113, Iss.3, 2009-08, pp. : c198-c202

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug‐eluting stents versus bare metal stents prior to noncardiac surgery

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 85, Iss. 4, 2015-03 ,pp. : 533-541

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical outcome of DES versus BMS

By  

INTERNAL MEDICINE JOURNAL, Vol. 45, Iss. 2, 2015-02 ,pp. : 203-211

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical efficacy of drug-eluting stents in patients with diabetes

By Dieter Robert S   Ahmed Mohammed   Ikram Sohail   Pacanowski Jr John P   Nanjundappa Aravinda  

Therapy, Vol. 3, Iss. 1, 2006-01 ,pp. : 1-3

Future Medicine

Access to resources Recommend Favorite

Drug-Eluting Stents Compared with Bare Metal Stents Improve Late Outcome after Saphenous Vein Graft but Not after Large Native Vessel Interventions

By  

Cardiology, Vol. 112, Iss. 1, 2008-06 ,pp. : 49-55

Karger

Access to resources Recommend Favorite

Drug‐eluting stents: Newer is better!

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 84, Iss. 7, 2014-12 ,pp. : 1061-1061

John Wiley & Sons Inc

Access to resources Recommend Favorite